This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Book Now
Menu
Book

Muhid Bin Shahid, PhD
Project Manager, External Development & Manufacture at AstraZeneca
Speaker

Profile

Muhid joined the Chemical Development department in Pharmaceutical Technology & Development at AstraZeneca in 2021 after completing PhD studies at University of Strathclyde. Since 2021, Muhid significantly contributed to oligonucleotide process development, with a focus on downstream processing, and have supported clinical drug substance manufactures for late-stage oligonucleotide projects. Since June 2025, Muhid has moved to Project Manager, External Development & Manufacture position in Clinical Manufacture & Supply department in Pharmaceutical Technology & Development at AstraZeneca.

Agenda Sessions

  • Streamlining Oligonucleotide Manufacture: Improving Efficiency and Sustainability via Implementation of Single Chromatography

    , 15:00
    View Session

At this event

Prev
Next
Michael Stager, PhD
Senior Development Engineer
Corden Pharma Colorado

See Muhid Bin at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now